Medpace Holdings, Inc. reported $2.78B of revenue over the trailing twelve months, +25% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.78B (to Q2 2026). Net income: $492M, trailing twelve months to Q2 2026. Free cash flow: $707M, trailing twelve months to Q2 2026. Operating margin: 21%, trailing twelve months to Q2 2026.

MEDPMedpace Holdings, Inc.

Healthcare

$612.15+23% 1Y

$612.15

$393.4252 weeks$630.21

MEDP as reported

Medpace Holdings, Inc. reported $2.78B of revenue over the trailing twelve months, +25% on the year before. 11 reported series are charted on this page, each one as filed.

$2.78B

Revenue, trailing twelve months · to Q2 2026 · +25% against the twelve months before

Net income: $492M
Net income · +17% year on year · trailing twelve months to Q2 2026
Free cash flow: $707M
Free cash flow · +22% year on year · trailing twelve months to Q2 2026
Operating margin: 21%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for MEDP, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.78B	+25%	Q2 2026
Net income	$492M	+17%	Q2 2026
EPS	$17.03	+27%	Q2 2026
Gross margin	29%	n/a	Q2 2026
Operating margin	21%	n/a	Q2 2026
Net margin	18%	n/a	Q2 2026
ROE	109%	n/a	Q2 2026
ROA	23%	n/a	Q2 2026
ROIC	68%	n/a	Q4 2023 · 10 quarters behind
Free cash flow	$707M	+22%	Q2 2026
P/E	36.0	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.